Sertraline ( DrugBank: Sertraline )

2 diseases

ID	Disease name (Link within this page)	Number of trials
6	Parkinson disease	2
206	Fragile X syndrome	1

6. Parkinson disease

Clinical trials : 2,307 / Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02917122 (ClinicalTrials.gov)	August 2015	30/6/2016	The Therapeutic Effect of Transcranial Direct Current Stimulation on Depression in Parkinson's Disease	The Therapeutic Effect of Transcranial Direct Current Stimulation on Depression in Parkinson's Disease	Parkinson Disease;Depression	Device: active tDCS;Drug: Sertraline;Device: sham tDCS	National Cheng-Kung University Hospital	NULL	Active, not recruiting	18 Years	75 Years	Both	40	Phase 1/Phase 2	NULL
2	NCT01437189 (ClinicalTrials.gov)	August 2011	16/9/2011	The Effects of Sertraline on Depression in Parkinson's Disease	Clinical Protocol of Self-Controlled Study on the Effects of Sertraline on Depression in Parkinson's Disease	Depression;Parkinson's Disease	Drug: Sertraline	Zhejiang University	NULL	Recruiting	35 Years	75 Years	Both	35	N/A	China

Clinical trials : 108 / Drugs : 91 - (DrugBank : 36) / Drug target genes : 52 - Drug target pathways : 77

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01474746 (ClinicalTrials.gov)	January 2012	10/11/2011	Trial of Sertraline to Treat Children With Fragile X Syndrome	A Controlled Trial of Sertraline in Young Children With Fragile X Syndrome	Fragile X Syndrome	Drug: Sertraline;Drug: Placebo	Randi J. Hagerman, MD	NULL	Completed	24 Months	68 Months	All	57	Phase 2	United States